You are here

My account
Tuesday 24 May 2016 16:30 - 19:30

There is a need for better understanding of the factors driving antibiotic resistance and the risk associated consequences. This inter-disciplinary event outlined its scale and impacts, and presented ideas on what government, health practitioners, businesses and the actuarial profession should do to address this global problem

Antibiotic resistance is perceived as a growing threat to health and well-being globally. It has led to a global increase in morbidity and mortality due to resistant bacterial infections. If left unchecked, common infections and routine surgeries could become life threating. However, the world has been slow to recognise the scale of the problem and to act as drug after drug encounters resistance and too few alternative treatments are being developed.

A video recording of the event is now available to watch.

Speakers:

Dr Meghan Perry, Clinical lecturer, University of Edinburgh
Clinician scientist specialising in infectious diseases. Her clinical work includes antimicrobial stewardship, infection consult rounds, care for inpatients and outpatients with HIV, hepatitis, tuberculosis, community-acquired, hospital-acquired and imported infections. Having completed a PhD on drug resistance in leishmaniasis her ongoing research work with Professor Mark Woolhouse at the University of Edinburgh focuses on antimicrobial resistance.
 
Matthew Edwards, Senior Consultant, Willis Towers Watson
Matthew Edwards is the Head of Mortality and Longevity in Willis Towers Watson’s life insurance practice. He has a particular interest in disease-based modelling, longer-term driver-based models of longevity, and using the views of medical experts to enhance our understanding of likely mortality trends. He is a member of the IFoA’s Mortality Research Steering Committee.
 
Nicola Oliver, Medical Director, Medical Intelligence
Nicola Oliver is the Director & Head of Longevity and Mortality at Medical Intelligence (UK) Limited and is responsible for furthering clients understanding of factors driving longevity and mortality risk. She has extensive experience of working with the UK National Health Service in hospital intensive care and in public health. She is a member of the Institute and Faculty of Actuaries, The Royal Society of Medicine and the Royal College of Nursing.
 

Event organiser

Contact Events Team for more information.

eventmanagement@actuaries.org.uk

0207 632 1498

CPD

CPD
2.00 hours

16.30 – 17.00 Registration

17.00 – 17.05 Introduction – Joseph Lu, Chair of the Mortality Research Steering Committee

17.05 – 18.05 Sessions:

  • Session 1: Clinical implication of antibiotic resistance – Dr Meghan Perry, Clinical lecturer, University of Edinburgh
  • Session 2: Antibiotic resistance and longevity improvements – Matthew Edwards, Senior Consultant, Willis Towers Watson
  • Session 3: Current developments and research in creating new antibiotics – Nicola Oliver, Medical Director, Medical Intelligence

18.05 – 18.50 Panel discussion and Q&A with speakers

18.50 – 19.00 Concluding remarks

19.00 – 19.30 Refreshments

Event Papers

Location

Address

Staple Inn Hall

High Holborn

London

WC1V 7QJ

UK

Nearest Public Transport

Staple Inn Hall is located close to Chancery Lane station on the Central line